Observational Study Evaluating Safety in Patients With Type 2 Diabetes Treated With NovoMix 30 or NovoMix 50 or NovoMix70 (Biphasic Insulin Aspart).

Trial Profile

Observational Study Evaluating Safety in Patients With Type 2 Diabetes Treated With NovoMix 30 or NovoMix 50 or NovoMix70 (Biphasic Insulin Aspart).

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Jan 2017

At a glance

  • Drugs Insulin aspart/insulin protamine aspart (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Acronyms Mix2Mix
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Nov 2009 Actual patient number (546) added as reported by ClinicalTrials.gov.
    • 20 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top